2022
DOI: 10.1016/j.jocs.2022.101772
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid genetic predictive modeling for finding optimal multipurpose multicomponent therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…A step-wise approach was proposed to choose drug combinations for compensating carbohydrate metabolism for T2DM patients [ 176 ]. The main carbohydrate metabolism indicator – glycated hemoglobin, arterial blood pressure, and the lipid profile indicator – low-density lipoprotein cholesterol were used as indicators for the prediction.…”
Section: The Application Of ML and Dl Models For The Management Predi...mentioning
confidence: 99%
“…A step-wise approach was proposed to choose drug combinations for compensating carbohydrate metabolism for T2DM patients [ 176 ]. The main carbohydrate metabolism indicator – glycated hemoglobin, arterial blood pressure, and the lipid profile indicator – low-density lipoprotein cholesterol were used as indicators for the prediction.…”
Section: The Application Of ML and Dl Models For The Management Predi...mentioning
confidence: 99%
“…ML and DL applications are also employed for managing T2MD and its evolutions; for example, a personalized postprandial-targeting diet, relying on an ML algorithm that integrates clinical and microbiome features, was used to predict personal postprandial glucose response, in order to control glycemic and metabolic health in patients with newly diagnosed T2DM [ 15 ]. Again, a stepwise approach, based on the combination of machine learning methods, probability graph models, classical statistical modeling tools, and in-house algorithm, was proposed to select drug combinations for compensating carbohydrate metabolism for T2DM patients [ 16 ]. ML-based predictors derived from baseline HbA1c level, comorbidities, demographic variables, and baseline metformin dosage were exploited for predicting the achievement and also for maintaining HbA1c < 7.0% after one year of metformin treatment [ 17 ].…”
Section: Introductionmentioning
confidence: 99%